Butyrylcholinesterase Antikörper (AbBy Fluor® 555)
Kurzübersicht für Butyrylcholinesterase Antikörper (AbBy Fluor® 555) (ABIN884628)
Target
Alle Butyrylcholinesterase (BCHE) Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
Klon
-
-
Kreuzreaktivität
- Human
-
Aufreinigung
- Purified by Protein G.
-
Immunogen
- Full length native protein purified from human
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
- IF(IHC-P) 1:50-200
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- 1 μg/μL
-
Buffer
- Aqueous buffered solution containing 0.01M TBS ( pH 7.4) with 1 % BSA, 0.03 % Proclin300 and 50 % Glycerol.
-
Konservierungsmittel
- ProClin
-
Vorsichtsmaßnahmen
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles.
-
Haltbarkeit
- 12 months
-
-
- Butyrylcholinesterase (BCHE)
-
Andere Bezeichnung
- BCHE
-
Hintergrund
-
Synonyms: Cholinesterase, Acylcholine acylhydrolase, Choline esterase II, CHE1, Butyrylcholine esterase, Pseudocholinesterase, butyrylcholinesterase.CHLE_HUMAN.
Background: Mutant alleles at the BCHE locus are responsible for suxamethonium sensitivity. Homozygous persons sustain prolonged apnea after administration of the muscle relaxant suxamethonium in connection with surgical anesthesia. The activity of pseudocholinesterase in the serum is low and its substrate behavior is atypical. In the absence of the relaxant, the homozygote is at no known disadvantage. [provided by RefSeq, Jul 2008].
-
Gen-ID
- 590
-
Pathways
- Peptide Hormone Metabolism
Target
-